Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 10/2011

01-10-2011 | Letter

Totally laparoscopic total gastrectomy and the challenge of esophagojejunostomy

Author: Theodore Liakakos

Published in: Surgical Endoscopy | Issue 10/2011

Login to get access

Excerpt

Laparoscopic surgery for the treatment of resectable and potentially curable gastric cancer has rapidly evolved over the last two decades. In a recent editorial analyzing the results of small randomized controlled trials and large-scale retrospective studies, it was pointed out that laparoscopy-assisted distal gastrectomy appears to be feasible and safe and does not affect the oncologic outcome of the patients with early gastric cancer. However, data on the safety and effectiveness of laparoscopic totally intracorporeal distal or total gastrectomy for early and advanced stages II and III disease are still insufficient to draw definitive conclusions [1]. …
Literature
1.
Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476PubMedCrossRef
2.
Bracale U, Marzano E, Nastro P, Barone M, Cuccurullo D, Cutini G, Corcione F, Pignata G (2010) Side-to-side esophagojejunostomy during totally laparoscopic total gastrectomy for malignant disease: a multicenter study. Surg Endosc 24(10):2475–2479PubMedCrossRef
3.
Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350PubMedCrossRef
4.
Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651PubMedCrossRef
5.
Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555PubMedCrossRef
6.
Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22(5):1402–1404PubMedCrossRef
7.
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449PubMedCrossRef
8.
Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719–726PubMedCrossRef
9.
Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249(4):695–696PubMedCrossRef
10.
Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406PubMedCrossRef
11.
Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17PubMedCrossRef
12.
Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043PubMedCrossRef
13.
Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586PubMedCrossRef
14.
Roukos DH, Katsios C, Liakakos T (2010) Genotype–phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545PubMedCrossRef
15.
Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype–phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48PubMedCrossRef
16.
Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995 author reply 1995–1996PubMedCrossRef
17.
Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678–2681PubMedCrossRef
18.
Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782PubMedCrossRef
19.
Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRef
20.
Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250PubMedCrossRef
21.
Roukos DH (2011) Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J 11(2):81–92PubMedCrossRef
22.
Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices 7(6):723–726PubMedCrossRef
23.
Roukos DH (2011) Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets. Expert Rev Med Devices 8(2):123–126PubMedCrossRef
24.
Roukos DH (2011) “Big” Science: Genome regulatory networks and novel molecular tools to improve health. Expert Rev Mol Diagn 11(2):123–126PubMedCrossRef
25.
Katsios C, Roukos DH (2011) Missing heritability, next-generation genome-wide association studies and primary cancer prevention: an Atlantean illusion? Future Oncol 7(4):477–480PubMedCrossRef
26.
Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416PubMedCrossRef
Metadata
Title
Totally laparoscopic total gastrectomy and the challenge of esophagojejunostomy
Author
Theodore Liakakos
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 10/2011
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1692-3

Other articles of this Issue 10/2011

Surgical Endoscopy 10/2011 Go to the issue

OriginalPaper

A natural orifice transrectal approach for oncologic resection of the rectosigmoid: an experimental study and comparison with conventional laparoscopy

OriginalPaper

The impact of preventable disruption on the operative time for minimally invasive surgery

Letter

Primum non nocere, deinde philosophare

OriginalPaper

Postprandial proximal gastric acid pocket in patients after laparoscopic Nissen fundoplication

Endoluminal Surgery

Assessment of a simple, novel endoluminal method for gastrotomy closure in NOTES

Letter

Technique, risks, and true impact of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery